Llwytho...
Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia
Long-acting pasireotide is an effective treatment option for acromegaly, but it is associated with hyperglycemia, which could impact its use in patients with diabetes. We present a case of a 53-year-old man with acromegaly and type 2 diabetes mellitus (glycated hemoglobin (HbA(1c)): 7.5%), who refus...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Bioscientifica Ltd
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5445444/ https://ncbi.nlm.nih.gov/pubmed/28567297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-17-0003 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|